Search Results - Wencai Lv

Discovery of first-in-class DOT1L inhibitors against the R231Q gain-of-function mutation in the catalytic domain with therapeutic potential of lung cancer by Zehui Tan, Ning Guo, Zhi Cao, Shuyu Liu, Jiayu Zhang, Deyi Ma, Jiahao Zhang, Wencai Lv, Nan Jiang, Linghe Zang, Lihui Wang, Xin Zhai

Connect to this object online.